Ultragenyx Pharmaceutical stock forecast
Ultragenyx Pharmaceutical (RARE) Stock Forecast & Price Target
RARE Analyst Ratings
RARE Stock 12 Month Forecast
Average Price Target
Mex$461.96▲(80.45% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Maxwell Skor | Morgan Stanley | Mex$408.25 | hold | 59.47%Upside | Reiterated | 11/16/26 | ||
| Ram Selvaraju | H.C. Wainwright | Mex$463.92 | buy | 81.22%Upside | Reiterated | 11/06/26 | ||
| Yigal Nochomovitz | Citi | Mex$593.81→Mex$408.25 | buy | 59.47%Upside | Reiterated | 11/06/26 | ||
| Eliana Merle | Barclays | Mex$649.48→Mex$593.81 | buy | 131.96%Upside | Reiterated | 11/05/26 | ||
| Allison Bratzel | Piper Sandler | Mex$668.04 | buy | 160.95%Upside | Reiterated | 11/05/26 | ||
| Joseph Schwartz | Leerink Partners | Mex$612.37 | buy | 139.21%Upside | Reiterated | 11/05/26 | ||
| Tazeen Ahmad | Bank of America Securities | Mex$371.13 | hold | 44.97%Upside | Reiterated | 11/04/26 | ||
| Salveen Richter | Goldman Sachs | Mex$352.58→Mex$315.46 | hold | 23.23%Upside | Reiterated | 11/04/26 | ||
| Whitney Ijem | Canaccord Genuity | Mex$723.71→Mex$630.93 | buy | 146.46%Upside | Reiterated | 11/04/26 | ||
| Laura Chico | Wedbush | Mex$463.92→Mex$408.25 | hold | 59.47%Upside | Reiterated | 11/04/26 | ||
| Luca Issi | RBC Capital | Mex$352.58 | hold | 37.73%Upside | Reiterated | 11/04/26 | ||
| Yaron Werber | TD Cowen | Mex$334.02→Mex$352.58 | buy | 37.73%Upside | Reiterated | 11/04/26 | ||
| Benjamin Burnett | Wells Fargo | Mex$334.02→Mex$352.58 | hold | 37.73%Upside | Reiterated | 11/03/26 | ||
| Kristen Kluska | Cantor Fitzgerald | Mex$723.71 | buy | 182.70%Upside | Reiterated | 11/03/26 | ||
| Joon Lee | UBS | Mex$296.91 | hold | 15.98%Upside | Initiated | 10/14/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Maxwell SkorMorgan Stanley | HoldReiteratedMex$408.25 | 11/16/26 | 59.47%Upside | ||
| Ram SelvarajuH.C. Wainwright | BuyReiteratedMex$463.92 | 11/06/26 | 81.22%Upside | ||
| Yigal NochomovitzCiti | BuyReiteratedMex$593.81→Mex$408.25 | 11/06/26 | 59.47%Upside | ||
| Eliana MerleBarclays | BuyReiteratedMex$649.48→Mex$593.81 | 11/05/26 | 131.96%Upside | ||
| Allison BratzelPiper Sandler | BuyReiteratedMex$668.04 | 11/05/26 | 160.95%Upside | ||
| Joseph SchwartzLeerink Partners | BuyReiteratedMex$612.37 | 11/05/26 | 139.21%Upside | ||
| Tazeen AhmadBank of America Securities | HoldReiteratedMex$371.13 | 11/04/26 | 44.97%Upside | ||
| Salveen RichterGoldman Sachs | HoldReiteratedMex$352.58→Mex$315.46 | 11/04/26 | 23.23%Upside | ||
| Whitney IjemCanaccord Genuity | BuyReiteratedMex$723.71→Mex$630.93 | 11/04/26 | 146.46%Upside | ||
| Laura ChicoWedbush | HoldReiteratedMex$463.92→Mex$408.25 | 11/04/26 | 59.47%Upside | ||
| Luca IssiRBC Capital | HoldReiteratedMex$352.58 | 11/04/26 | 37.73%Upside | ||
| Yaron WerberTD Cowen | BuyReiteratedMex$334.02→Mex$352.58 | 11/04/26 | 37.73%Upside | ||
| Benjamin BurnettWells Fargo | HoldReiteratedMex$334.02→Mex$352.58 | 11/03/26 | 37.73%Upside | ||
| Kristen KluskaCantor Fitzgerald | BuyReiteratedMex$723.71 | 11/03/26 | 182.70%Upside | ||
| Joon LeeUBS | HoldInitiatedMex$296.91 | 10/14/26 | 15.98%Upside |
Best Analysts Covering Ultragenyx Pharmaceutical
Copying Yigal Nochomovitz's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +2.11% per trade.
Copying Whitney Ijem's trades and holding each position for 1 Year would result in 31.58% of your transactions generating a profit, with an average return of -11.18% per trade.
Copying Yaron Werber's trades and holding each position for 2 Years would result in 18.75% of your transactions generating a profit, with an average return of -25.91% per trade.
RARE Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 14 | 24 | 36 | 37 | 22 |
| Buy | 4 | 7 | 8 | 6 | 3 |
| Hold | 4 | 6 | 22 | 22 | 26 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 37 | 66 | 65 | 51 |
In the current month, RARE has received 25 Buy Ratings, 26 Hold Ratings, and 0 Sell Ratings. RARE average Analyst price target in the past 3 months is 461.96.
RARE Financial Forecast
RARE Earnings Forecast
Next quarter’s earnings estimate for RARE is MXN 44.52 with a range of MXN 38.85 to MXN 55.02. The previous quarter’s EPS was -MXN 21.56. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RARE Sales Forecast
Next quarter’s sales forecast for RARE is MXN 4.21B with a range of MXN 3.79B to MXN 4.44B. The previous quarter’s sales results were MXN 3.22B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

